FIELD: pharmaceutics.
SUBSTANCE: invention refers to synthetic immunomodulators. Disclosed is the use of a cyclic derivative of barbituric acid (1-o-fluorobenzoyl-5-phenyl-5-ethyl-barbituric acid) – halonal as an immunomodulator.
EFFECT: halonal increases the spleen lymphoid cell proliferative activity and delayed type hypersensitivity manifestation; invention can be used as a modulator of functional activity of the immune system and its cellular elements both in norm, and in pathology (chronic alcoholism).
1 cl, 2 dwg, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMODULATOR | 2018 |
|
RU2691143C1 |
| IMMUNOMODULATOR | 2020 |
|
RU2747986C1 |
| METHOD FOR REDUCING ALCOHOLIC MOTIVATION IN MICE | 2020 |
|
RU2744411C1 |
| IMMUNODEPRESSANT | 2016 |
|
RU2637642C1 |
| IMMUNODEPRESSANT | 2016 |
|
RU2637643C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2253444C1 |
| IMMUNOMODULATING AGENT | 1993 |
|
RU2108100C1 |
| AGENT WITH COMBINED NORMALIZING EFFECT ON IMMUNE AND DIGESTIVE BODY SYSTEMS | 2015 |
|
RU2611377C2 |
| IMMUNOSUPRESSOR | 2003 |
|
RU2253448C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2252757C1 |
